Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human ST2/IL-33R Antibody, R&D Systems™

Goat Polyclonal Antibody has been used in 12 publications
Supplier: R&D Systems AF523
This item is not returnable.
View return policy
Description
ST2/IL-33R Polyclonal specifically detects ST2/IL-33R in Human samples. It is validated for Western Blot, Simple Western, Flow Cytometry, Immunohistochemistry, Neutralization, CyTOF-ready.Specifications
ST2/IL-33R | |
Polyclonal | |
Unconjugated | |
BAA02233 | |
IL1RL1 | |
S. frugiperda insect ovarian cell line Sf 21-derived recombinant human ST2/IL-33 R Lys19-Phe328 Accession # BAA02233 | |
100 μg | |
Primary | |
Detects human ST2/IL-33 R in direct ELISAs and Western blots. In direct ELISAs, less than 10% cross-reactivity with recombinant mouse ST2/IL-33 R is observed. | |
Human | |
IgG |
Western Blot, Flow Cytometry, Immunohistochemistry, Neutralization, CyTOF | |
LYOPH | |
Western Blot 0.2 ug/mL, Simple Western 2 ug/mL, Flow Cytometry 0.25 ug/10^6 cells, Immunohistochemistry 1-15 ug/mL, Neutralization 0.1-0.6 ug/mL, CyTOF-ready | |
DER4, DER4ST2growth stimulation-expressed, FIT-1, IL-1 R4, IL1R4, IL-1R4, IL-1RL1, IL-33 R, IL33R, IL-33R, interleukin 1 receptor-like 1, interleukin 1 receptor-related protein, interleukin-1 receptor-like 1, Ly84, MGC32623, Protein ST2, ST2L, ST2V, T1, T1homolog of mouse growth stimulation-expressed | |
Goat | |
Affinity Purified | |
RUO | |
9173 | |
Reconstitute at 0.2 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction